The consumables segment by product and service type is estimated to lead the market growth during the forecast period.

According to a new market research study of “Middle East and Africa High Throughput Screening Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product and Service, Technology, Application, End User and Country.” The Middle East and Africa high throughput screening market is expected to reach US$ 1,141.53 million by 2028 from US$ 763.08 million in 2021; it is estimated to grow at a CAGR of 5.9% from 2021 to 2028. The report highlights trends prevailing in the Middle East and Africa high throughput screening market and the factors driving market along with those that act as hindrances. 

The market is witnessing the use of artificial intelligence (AI) in high-throughput screening (HTS). Using AI in HTS is an important objective of the pharmaceutical and biotech industry. Using AI-based data processing/control software, liquid handling systems, and sensitive detectors, and high-throughput screening allows a researcher to quickly conduct millions of chemicals, genetic, or pharmacological tests. Through this process, one can rapidly identify active compounds, antibodies, or genes that modulate a biomolecular pathway. Most of the top biopharmaceutical companies have started internal programs and are collaborating to develop AI platforms for increasing the research power of immuno-oncology drugs, metabolic-disease therapies, cancer treatments, and many other therapeutic targets. In July 2020, Cerevel Therapeutics—a company dedicated to research and development in neuroscience diseases therapeutics—and Cyclica—an AI-based drug discovery company—entered into a collaboration to accelerate the discovery of novel medicines in neuroscience. Cyclica’s world-class AI platform for high-throughput screening in compound identification and optimization can efficiently identify new therapeutic molecules for Cerevel Therapeutics. Such strategic developments show that AI-based high-throughput screening technologies will revolutionize drug discovery. Furthermore, there is an increase in demand for high-throughput screening owing to the need for screening new chemical entities with more efficiency, as well as ensure productive optimization of drug molecules. Technological advancements in high-throughput screening techniques and the launch of innovative systems by various market players are driving the market growth.

The Middle Eastern economy is severely affected due to the exponential growth of COVID-19 cases in the region. Since the beginning of 2020, the COVID-19 pandemic has caused enormous health, social and economic impacts, which is likely to continue in 2021. Currently, the COVID-19 diagnostic testing industry is witnessing an upsurge on account of a growing number of cases. Hence, with many laboratory and research services under acute pressure, the market for HTS is expected to be positively impacted in the region.

The Middle East and Africa high throughput screening market, based on product and service is segmented into consumables, instruments, accessories, software, and services. The consumables segment is further sub-segmented into reagents and assay kits and laboratory equipment. Also, the instruments are further sub-divided into liquid handling systems and detection systems. The Middle East and Africa high throughput screening market based on the technology was segmented into cell-based assays, lab-on-a-chip, ultra-high-throughput screening, bioinformatics, and label-free technology. The Middle East and Africa high throughput screening market based on the application is segmented into drug discovery, biochemical screening, life sciences research, and other applications. The Middle East and Africa high throughput screening market based on the end user was segmented into pharmaceutical and biotechnology companies, academic and government institutes, contract research organizations (CRO) and others. Geographically, the Middle East and Africa high throughput screening market can be sub-segmented into UAE, Saudi Arabia, South Africa and Rest of Middle East and Africa.

Axxam S.p.A, Corning Incorporated, Molecular Devices, LLC., Hamilton Company, Perkin Elmer, Inc., THERMO FISHER SCIENTIFIC INC., MERCK KGaA and Tecan Trading AG are among the leading companies operating in the Middle East and Africa high throughput screening market.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com